Matthew Joseph Eckler
CIK: 0002156044
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PMVP
PMV Pharmaceuticals, Inc.
Director
Discretionary Trading P&L
Holdings
About Eckler Matthew Joseph
Eckler Matthew Joseph (SEC CIK 0002156044) files insider reports with the SEC as Director of PMV Pharmaceuticals, Inc. (PMVP).
Signal8 holds 2 ownership filings by Eckler Matthew Joseph (1 Form 3, 1 Form 4), filed on Oct 5, 2026. Those filings report 1 transaction, the latest on Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Eckler Matthew Joseph's filings is in PRINCETON, NJ.
Recent filings by Eckler Matthew Joseph
- Oct 1, 2026: Grant or award of PMVP derivative securities (Form 4, code A).
Other insiders filing for PMV Pharmaceuticals, Inc. (PMVP)
- Stelzer Laurie, Director
- LEVINE ARNOLD J, Director
- Gallagher Carol Giltner, Director
- FLOWERS KIRSTEN, Director
- BAUM CHARLES M, Director
- Carulli Michael, Chief Financial Officer